Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives
Rongxing Liu, Cécile Mathieu, Jérémy Berthelet, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7027-7027
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 38
Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes
Haaglim Cho, Chien-Cheng Lai, Rémy Bonnavion, et al.
Science (2025) Vol. 387, Iss. 6734, pp. 674-682
Closed Access | Times Cited: 2
Protein tyrosine phosphatase 1B in metabolic diseases and drug development
Mirela Delibegović, Sergio Dall’Angelo, Ruta Dekeryte
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 6, pp. 366-378
Closed Access | Times Cited: 10
Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs
Andrea Coronell‐Tovar, Juan Pablo Pardo, A. Rodríguez-Romero, et al.
FEBS Letters (2024)
Open Access | Times Cited: 10
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Unveiling the potential of marine-derived diterpenes from the order Alcyonacea as promising anti-obesity agents
Mohamed A. Tammam, Omnia Aly, Florbela Pereira, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100175-100175
Open Access | Times Cited: 5
Native dynamics and allosteric responses in PTP1B probed by high‐resolution HDX‐MS
Virgil A. Woods, Rinat R. Abzalimov, D.A. Keedy
Protein Science (2024) Vol. 33, Iss. 6
Open Access | Times Cited: 5
Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases
Dominika Kołodziej, Łukasz Sobczak, Krzysztof Z. Łączkowski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7033-7033
Open Access | Times Cited: 5
Deciphering Potent Protein Tyrosine Phosphatase‐1B Inhibitors Through In silico Molecular Docking, MMGBSA, and Molecular Dynamics
Vishnu Malakar, Dhanabal Palanisamy, Bryan Gowramma, et al.
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Efficient and Explainable Virtual Screening of Molecules through Fingerprint-Generating Networks Integrated with Artificial Neural Networks
Rivaaj Monsia, Sudeep Bhattacharyay
ACS Omega (2025)
Open Access
Unveiling the Multitarget Potential of a Rare Caffeoyl Ester from Artemisia capillaris for Diabetes Mellitus: An Integrated In Vitro and In Silico Study
Md. Nurul Islam, Manh Tuan Ha, Byung Sun Min, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1286-1286
Open Access
Design, synthesis, molecular docking and anticancer activity evaluation of methyl salicylate based thiazoles as PTP1B inhibitors
Dominika Kołodziej, Łukasz Sobczak, Wojciech Płaziński, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Investigation of Compounds Found in Ginger (Curcuma longa L.) as Inhibitors for PTP1B for the Treatment of Type 2 Diabetes Using Molecular Docking and Molecular Dynamics Approaches
Selami Ercan, Gökçe Çiçek Arslan, Necmettin Pirinççioğlu
ChemistrySelect (2025) Vol. 10, Iss. 6
Open Access
Discovery of novel oleanolic acid glycoside derivatives targeting PTP1B/PI3K/AKT signaling pathway for the treatment of breast cancer
Xiaoping Song, Lina Wang, Yao Liu, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108296-108296
Closed Access
The Role of PTP1B in Cardiometabolic Disorders and Endothelial Dysfunction
Mona Sawali, Muhammad Zahid, Shahenda Salah Abdelsalam, et al.
Journal of drug targeting (2025), pp. 1-39
Closed Access
Combined in vitro and in silico approach to define alangimarckine from Thunbergia mysorensis leaves as a potential inhibitor of α-glucosidase
N. R. Kokila, B. Mahesh, Ramith Ramu, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-20
Closed Access
In Silico Screening and Identification of Antidiabetic Inhibitors Sourced from Phytochemicals of Philippine Plants against Four Protein Targets of Diabetes (PTP1B, DPP-4, SGLT-2, and FBPase)
Mark Andrian B. Macalalad, Arthur A. Gonzales
Molecules (2023) Vol. 28, Iss. 14, pp. 5301-5301
Open Access | Times Cited: 14
Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents
Zunhua Yang, Yuqi Ying, Shaobing Cheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7569-7584
Closed Access | Times Cited: 4
Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics
Yan Sun, Frank A. Dinenno, P. L. Tang, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 4
PTP1B knockdown alleviates BMSCs senescence via activating AMPK-mediated mitophagy and promotes osteogenesis in senile osteoporosis
Qiankun Yang, YuChi Zou, Xiaoyu Wei, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166795-166795
Closed Access | Times Cited: 11
Structural and molecular insights of protein tyrosine phosphatase 1B (PTP1B) and its inhibitors as anti-diabetic agents
Abhik Paul, Arnab Sarkar, Tanmoy Banerjee, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136258-136258
Closed Access | Times Cited: 10
Metformin as adjuvant treatment in hepatitis C virus infections and associated complications
Dylan Landis, Alex Sutter, Sachi Khemka, et al.
The American Journal of the Medical Sciences (2024) Vol. 368, Iss. 2, pp. 90-98
Closed Access | Times Cited: 3
Click Reaction Inspired Enzyme Inhibitors in Diabetes Care: An Update in the Field of Chronic Metabolic Disorder
Deeksha Mudgal, Nisha Yadav, Gaurav Kumar Srivastava, et al.
Current Pharmaceutical Design (2024) Vol. 31, Iss. 4, pp. 261-291
Closed Access | Times Cited: 3
Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors
Edward A. Fitzgerald, Darius Vagrys, Giulia Opassi, et al.
SLAS DISCOVERY (2023) Vol. 29, Iss. 1, pp. 40-51
Open Access | Times Cited: 9
Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4(1H)-Ones
К. В. Деркач, Maxim Gureev, Anastasia A. Babushkina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4498-4498
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top